Hinge Health (HNGE) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Hinge Health

NYSE•Healthcare•Health Information Services

$93.73+1.34(0.01%)Pre-market

Market Cap

$7.48B

P/E

59.3x

P/S

8.9x

P/B

21.7x

Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founded in 2012 and is headquartered in San Francisco, California.

How this company scores

GoodMetricSide Score: 71/100

Strongest: Profitability (22/25); weakest: Balance Sheet & Red Flags (15/25).

Profitability22/25

Growth16/25

Balance Sheet & Red Flags15/25

Cash & Earnings Quality18/25

Strengths

High ROERising earningsInterest easily coveredCash-backed earnings

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 59.3x5y range 59.3x – 59.3x

P/S · 8.9x5y range 3.8x – 8.9x

P/B · 21.7x5y range 13.1x – 25.9x

Currently near its 5-quarter median.

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

High Risk

Margin Pressure

Red Flag

The company posted negative operating margins in recent quarters — core operations are unprofitable.

Share Dilution

Red Flag

Shares outstanding increased 79.8% — significant dilution, likely from stock compensation or capital raises.

Price & Volume

Market Cap $7.48B

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $843.89M
Q. Revenue: $212.82M
TTM EBITDA: $111.53M
TTM Op. Income: $106.81M
Q. Op. Income: $40.44M
TTM Net Income: $126.21M
Q. Net Income: $43.69M
EPS: $0.55
Shares Out.: $78.97M

$843.89M in TTM revenue grew from zero YoY, reaching $212.82M last quarter. TTM EBITDA of $111.53M and TTM operating income of $106.81M show growth is flowing through to the bottom line. TTM net income of $126.21M means revenue is converting into profit. Across the last 5 quarters, TTM revenue has risen for 2 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 86.4%
EBITDA Margin: 19.5%
Op. Margin: 19.0%
Net Margin: 20.5%

Op. margin of 19.0% is up 436.5% YoY — cost efficiency is improving. Net margin at 20.5% and gross margin of 86.4% show how much of each revenue dollar survives to profit. Across the last 5 quarters, operating margin has risen for 4 consecutive quarters — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 59.3x
P/S Ratio: 8.9x
P/B Ratio: 21.7x

At 59.3x P/E, the stock trades above typical market levels — the market expects above-average growth. P/S of 8.9x and P/B of 21.7x provide additional context. Use the growth and margin sections to judge whether the multiple is justified.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $827.40M
Cash: $286.22M
Long-Term Debt: N/A
Book Value: $344.33M
D/E Ratio: N/A
Debt/EBITDA: 0.0

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $101.41M
TTM Free Cash Flow: $290.12M
FCF Margin: 34.4%
FCF / Net Income: 2.3

TTM FCF of $290.12M on $101.41M in operating cash flow. The FCF / Net Income ratio of 2.3x means free cash flow covers net income — earnings are backed by cash. Across the last 5 quarters, free cash flow has risen for 2 consecutive quarters — an improving trend.